Skip to main content
Log in

Phase-II-Studie zur Malariatherapie

Monoklonaler Antikörper zur Behandlung der P.-falciparum-bedingten Malaria

  • Journalclub
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. RTS,S Clinical Trials Partnership. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015;386:31-45

  2. Sissoko MS, Healy SA, Katile A et al. Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial. Lancet Infect Dis. 2022;22:377-89

  3. Alonso PL, Sacarlal J, Aponte JJ et al. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet. 2004;364:1411-20

  4. Polhemus ME, Remich SA, Ogutu BR et al. Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area. PLoS One. 2009;4(7):e6465

  5. Bojang KA, Milligan PJ, Pinder M et al. Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in the Gambia: a randomised trial. Lancet. 2001;358:1927-34

  6. Wang LT, Pereira LS, Flores-Garcia Y et al. A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver. Immunity. 2020;53(4):733.e8-744.e8

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Adrian Gillissen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gillissen, A. Monoklonaler Antikörper zur Behandlung der P.-falciparum-bedingten Malaria. Pneumo News 15, 25–26 (2023). https://doi.org/10.1007/s15033-022-3455-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-022-3455-3

Navigation